Have a personal or library account? Click to login
Effect of exogenous transcription factors integration sites on safety and pluripotency of induced pluripotent stem cells Cover

Effect of exogenous transcription factors integration sites on safety and pluripotency of induced pluripotent stem cells

By: S Yin,  W Li,  G Yang,  Y Cheng,  Q Yi,  S Fan,  Q Ma and  F Zeng  
Open Access
|Aug 2020

References

  1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-676.
  2. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, et al. iPS Cells produce viable mice through tetraploid complementation. Nature. 2009; 461(7260): 86-90.
  3. Zhao XY, Lv Z, Liu W, Zeng F, Zhou Q. Production of mice using iPS cells and tetraploid complementation. Nat Protoc. 2010; 5(5): 963-971.
  4. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391): 1145-1147.
  5. Wilmut I, Schnieke AE, Mc Whir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385(6619): 810-813.
  6. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009; 460(7251): 53-59.
  7. Reboun M, Rybova J, Dobrovolny R, Vcelak J, Veselkova T, Storkanova G, et al. X-Chromosome inactivation analysis in different cell types and induced pluripotent stem cells elucidates the disease mechanism in a rare case of mucopolysaccharidosis type II in a female. Folia Biol (Praha). 2016; 62(2): 82-89.
  8. Kaye JA, Finkbeiner S. Modeling Huntington’s disease with induced pluripotent stem cells. Mol Cell Neurosci. 2013; 56: 50-64.
  9. Byers B, Lee HL, Reijo Pera R. Modeling Parkinson’s disease using induced pluripotent stem cells. Curr Neurol Neurosci Rep. 2012; 12(3): 237-42.
  10. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012; 4(145): 145ra104.
  11. Sala L, Yu Z, Ward-van Oostwaard D, van Veldhoven JP, Moretti A, Laugwitz KL, et al. A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Mol Med. 2016; 8(9): 1065-1081.
  12. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007; 318(5858): 1920-1923.
  13. Yang G, Shi W, Hu X, Zhang J, Gong Z, Guo X, et al. Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia. Haematologica. 2014; 99(8): 1304-1311.
  14. Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, et al. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017; 376(11): 1038-1046.
  15. Sugita S, Iwasaki Y, Makabe K, Kamao H, Mandai M, Shiina T, et al. Successful transplantation of retinal pigment epithelial cells from MHC momozygote iPSCs in MHC-matched models. Stem Cell Rep. 2016; 7(4): 635-648.
  16. Cyranoski D. ‘Reprogrammed’ stem cells approved to mend human hearts for the first time. Nature. 2018; 557(7707): 619-620.
  17. Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model. Nature. 2017, 548(7669):592-596.
  18. Cyranoski D. ‘Reprogrammed’ stem cells implanted into patient with Parkinson’s disease. Nature News, November 2018 https://www.nature.com/articles/d41586-018-07407-9).
  19. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5): 861-872.
  20. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. RTCD: Retroviral tagged cancer gene database. Nucleic Acids Res. 2004; 32(Suppl 1): D523-D527.
  21. Zhang X, Firestein S. The olfactory receptor gene superfamily of the mouse. Nat Neurosci. 2002; 5(2): 124-133.
  22. Young JM, Shykind BM, Lane RP, Tonnes-Priddy L, Ross JA, Walker M, et al. Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels. Genome Biol. 2003; 4(11): R71.
  23. DiMagno MJ, Williams JA, Hao Y, Ernst SA, Owyang C. Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2004; 287(1): G80-G87.
  24. Vaughan AE, Halbert CL, Wootton SK, Miller AD. Lung cancer in mice induced by the Jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation. Mol Cancer Res. 2012; 10(1): 86-95.
  25. Ochman H, Gerber AS, Hartl DL. Genetic applications of an inverse polymerase chain reaction. Genetics. 1988; 120(3): 621-623.
  26. Telesnitsky A, Goff SP. Reverse transcriptase and the generation of retroviral DNA. In: Coffin JM, Hughes SH, Varmus HE, Editors. Retroviruses. Cold Spring Harbor (NY, USA): Cold Spring Harbor Laboratory Press. 1997: 121-160.
  27. Varas F, Stadtfeld M, de Andres-Aguayo L, Maherali N, di Tullio A, Pantano L, et al. Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions. Stem Cells. 2009; 27(2): 300-386.
  28. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008; 321(5889): 699-702.
  29. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol, 2004; 2(8): E234.
  30. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G. Locus control regions. Blood. 2002; 100(9): 3077-3086.
  31. McNamara-Schroeder KJ, Hennessey RF, Harding GA, Jensen RC, Stumph WE. The Drosophila U1 and U6 gene proximal sequence elements act as important determinants of the RNA polymerase specificity of small nuclear RNA gene promoters in vitro and in vivo. J Biol Chem. 2001; 276(34): 31786-31792.
  32. Slesarev A, Viswanathan L, Tang Y, Borgschulte T, Achtien K, Razafsky D, et al. CRISPR/CAS9 targeted CAPTURE of mammalian genomic regions for characterization by NGS. Sci Rep. 2019; 9(1): 3587.
  33. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 2005; 6(8): 635-645.
  34. Sadelain M, Papapetrou EP, Bushman FD. Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer. 2012; 12(1): 51-58.
  35. Tong M, Lv Z, Liu L, Zhu H, Zheng QY, Zhao XY, et al. Mice generated from tetraploid complementation competent iPS cells show similar developmental features as those from ES cells but are prone to tumorigenesis. Cell Res. 2011; 21(11): 1634-1637.
Language: English
Page range: 5 - 13
Published on: Aug 26, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2020 S Yin, W Li, G Yang, Y Cheng, Q Yi, S Fan, Q Ma, F Zeng, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.